COVID-19 Antigen Rapid Test – GREEN SPRING® 25-pack – TOP 10 best tests

25 Piece

SKU: 4335-25 Category: EAN: 4250415678417

suitable for detection of Omicron and other mutations

4 sampling methods
● Saliva (lolly test) – especially suitable for children!
● Anterio-nasal swab (nose in front)
● Nasopharyngeal swab (nose and throat)
● Oropharyngeal swab (mouth-throat)
sensitivity 96,77% und specificity 100,00%

fast and reliable test results in only 15 minutes

● BfArM listet (BfArM-Test-ID: AT1188/21)
● Paul-Ehrlich-Institut proof
● HSC common list (Device-ID: 2109)
● PZN: 17394138

We look forward to your enquiry for larger quantities

Green Spring
GREEN SPRING
Rapid Test
Image is not available
Image is not available
Green Spring EN
GREEN SPRING
Rapid Test
Image is not available
Image is not available
Clungene Schnelltest DE
Clungene
Schnelltest
Image is not available
Box Schnelltest Clungene
Clungene Schnelltest EN
Clungene
Rapid Test
Image is not available
Box Schnelltest Clungene




Advantages
• BfArM Zulassung
• easy to handle
• fast and reliable test results in only 15 minutes
• 4 sampling methods
• Room temperature storage
• no cross-reactivity with different Coronaviren wie MERS, 229E, NL63, KHU1 oder Influenza A, B

Sensitivity 96,77%
describes how well a test actually detects infected persons and how many infected persons pass through its meshes. In statistics, this is referred to as false-negative results. The closer the value is to 100 percent, the more reliably the test detects all infected persons.
specificity 100,00%
describes how rarely a test falsely classifies people as infected. This is about the statistically false-positive results. Again, the closer the value is to 100 per cent, the better.

Purpose of use
The Green Spring® SARS-CoV-2 Antigen Rapid Test is for the rapid qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in human saliva, nasal, nasopharyngeal or throat swab specimens. The results are used for the detection of SARS-CoV-2 antigen. The antigen is generally detectable in upper respiratory tract specimens during the acute phase of infections. Positive results do not rule out bacterial infection or co-infection with other viruses. The pathogen detected may not be the sole cause of the disease.

Principle of testing
The Green Spring® SARS-CoV-2 Antigen Rapid Test is a qualitative, membrane-based immunoassay for the detection of SARS-CoV-2 nucleocapsid protein antigens. The test line region is coated with SARS-CoV-2 antibody. The sample reacts with the SARS-CoV-2 antibody in the test line region. If the sample contains SARS-CoV-2 antigens, a coloured line appears in the test line area (T) as a relevant result. As a procedural control, a coloured line appears in the control line area (C), indicating that the correct volume of sample has been added and membrane wetting has occurred correctly.

BfArM listet and proof passed by Paul-Ehrlich-Institut – listet and refundable


Produktdatenblatt

Rapid tests are excluded from return and exchange

Title Type Size
Instructions-for-use-4335-25-DE.pdf application/pdf 395 KB
Instructions-for-use-4335-25-EN.pdf application/pdf 264 KB
Instructions-for-use-4335-25-IT.pdf application/pdf 277 KB
Declaration-of-Conformity-4335-25-2020_11_09.pdf application/pdf 763 KB
Product-data-sheet-4335-25-DE.pdf application/pdf 14 MB